In-vitro Recording of Adult Zebrafish Heart Electrocardiogram- A Platform for Pharmacological Testing

Chia Ti Tsai, Cho Kai Wu, Jiunn-Lee Lin, Juey Jen Hwang

Research output: Contribution to journalArticle

Abstract

Background: Recently zebrafish has become a powerful vertebrate model system for cardiac arrhythmia and another advantage is that the heart could be rapidly excised for in-vitro electrophysiological recording. Methods: We made direct in-vitro recordings of adult zebrafish heart ECG using the microelectrode array and tested the effects of various drugs on zebrafish heart ECG. Results: The QT interval change in the ECG was verified by optically mapped action potential duration (APD). The mean optically mapped APD was 308±30 ms, which was close to the QT interval in ECG (p=0.815). We found that sympathomimetic drug isoproterenol increased HR, whereas L-type calcium channel blocker verapamil decreased HR. Sodium channel blocker quinidine and L-type calcium channel activator BayK8644 prolonged QTc interval in a dose-dependent manner (515±24 ms and 519±27 ms, respectively, both p<0.01). The APD was also prolonged accordingly. Both rapidly and slowly activating delayed rectifier potassium channel (IKr and IKs) blockers E4031 and Chromanol 293B, respectively, also prolonged QTc interval in a dose-dependent manner (523±25 ms and 529±27 ms, respectively, both p<0.01). Quinidine, E4031 and Chromanol 293B also decreased HR. Conclusions: Direct in-vitro recording of adult zebrafish heart is an efficient platform for test of drugs which exert electrophysiological effects on cardiomyocytes, and perturbation of ionic channels that are responsible for human long QT syndrome also modulates QT interval in adult zebrafish heart.

Original languageEnglish
Number of pages1
JournalJournal of Arrhythmia
Volume27
Issue number4
DOIs
Publication statusPublished - Jan 1 2011
Externally publishedYes

Fingerprint

Zebrafish
Electrocardiography
Pharmacology
Action Potentials
L-Type Calcium Channels
Quinidine
Calcium Channel Agonists
Sodium Channel Blockers
Long QT Syndrome
Sympathomimetics
Calcium Channel Blockers
Microelectrodes
Verapamil
Ion Channels
Isoproterenol
Cardiac Myocytes
Pharmaceutical Preparations
Vertebrates
Cardiac Arrhythmias
In Vitro Techniques

Keywords

  • electrocardiogram
  • long QT
  • zebrafish

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

In-vitro Recording of Adult Zebrafish Heart Electrocardiogram- A Platform for Pharmacological Testing. / Tsai, Chia Ti; Wu, Cho Kai; Lin, Jiunn-Lee; Hwang, Juey Jen.

In: Journal of Arrhythmia, Vol. 27, No. 4, 01.01.2011.

Research output: Contribution to journalArticle

@article{f533a6b0071f4a97986e65e67050a711,
title = "In-vitro Recording of Adult Zebrafish Heart Electrocardiogram- A Platform for Pharmacological Testing",
abstract = "Background: Recently zebrafish has become a powerful vertebrate model system for cardiac arrhythmia and another advantage is that the heart could be rapidly excised for in-vitro electrophysiological recording. Methods: We made direct in-vitro recordings of adult zebrafish heart ECG using the microelectrode array and tested the effects of various drugs on zebrafish heart ECG. Results: The QT interval change in the ECG was verified by optically mapped action potential duration (APD). The mean optically mapped APD was 308±30 ms, which was close to the QT interval in ECG (p=0.815). We found that sympathomimetic drug isoproterenol increased HR, whereas L-type calcium channel blocker verapamil decreased HR. Sodium channel blocker quinidine and L-type calcium channel activator BayK8644 prolonged QTc interval in a dose-dependent manner (515±24 ms and 519±27 ms, respectively, both p<0.01). The APD was also prolonged accordingly. Both rapidly and slowly activating delayed rectifier potassium channel (IKr and IKs) blockers E4031 and Chromanol 293B, respectively, also prolonged QTc interval in a dose-dependent manner (523±25 ms and 529±27 ms, respectively, both p<0.01). Quinidine, E4031 and Chromanol 293B also decreased HR. Conclusions: Direct in-vitro recording of adult zebrafish heart is an efficient platform for test of drugs which exert electrophysiological effects on cardiomyocytes, and perturbation of ionic channels that are responsible for human long QT syndrome also modulates QT interval in adult zebrafish heart.",
keywords = "electrocardiogram, long QT, zebrafish",
author = "Tsai, {Chia Ti} and Wu, {Cho Kai} and Jiunn-Lee Lin and Hwang, {Juey Jen}",
year = "2011",
month = "1",
day = "1",
doi = "10.4020/jhrs.27.OP32_2",
language = "English",
volume = "27",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - In-vitro Recording of Adult Zebrafish Heart Electrocardiogram- A Platform for Pharmacological Testing

AU - Tsai, Chia Ti

AU - Wu, Cho Kai

AU - Lin, Jiunn-Lee

AU - Hwang, Juey Jen

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Background: Recently zebrafish has become a powerful vertebrate model system for cardiac arrhythmia and another advantage is that the heart could be rapidly excised for in-vitro electrophysiological recording. Methods: We made direct in-vitro recordings of adult zebrafish heart ECG using the microelectrode array and tested the effects of various drugs on zebrafish heart ECG. Results: The QT interval change in the ECG was verified by optically mapped action potential duration (APD). The mean optically mapped APD was 308±30 ms, which was close to the QT interval in ECG (p=0.815). We found that sympathomimetic drug isoproterenol increased HR, whereas L-type calcium channel blocker verapamil decreased HR. Sodium channel blocker quinidine and L-type calcium channel activator BayK8644 prolonged QTc interval in a dose-dependent manner (515±24 ms and 519±27 ms, respectively, both p<0.01). The APD was also prolonged accordingly. Both rapidly and slowly activating delayed rectifier potassium channel (IKr and IKs) blockers E4031 and Chromanol 293B, respectively, also prolonged QTc interval in a dose-dependent manner (523±25 ms and 529±27 ms, respectively, both p<0.01). Quinidine, E4031 and Chromanol 293B also decreased HR. Conclusions: Direct in-vitro recording of adult zebrafish heart is an efficient platform for test of drugs which exert electrophysiological effects on cardiomyocytes, and perturbation of ionic channels that are responsible for human long QT syndrome also modulates QT interval in adult zebrafish heart.

AB - Background: Recently zebrafish has become a powerful vertebrate model system for cardiac arrhythmia and another advantage is that the heart could be rapidly excised for in-vitro electrophysiological recording. Methods: We made direct in-vitro recordings of adult zebrafish heart ECG using the microelectrode array and tested the effects of various drugs on zebrafish heart ECG. Results: The QT interval change in the ECG was verified by optically mapped action potential duration (APD). The mean optically mapped APD was 308±30 ms, which was close to the QT interval in ECG (p=0.815). We found that sympathomimetic drug isoproterenol increased HR, whereas L-type calcium channel blocker verapamil decreased HR. Sodium channel blocker quinidine and L-type calcium channel activator BayK8644 prolonged QTc interval in a dose-dependent manner (515±24 ms and 519±27 ms, respectively, both p<0.01). The APD was also prolonged accordingly. Both rapidly and slowly activating delayed rectifier potassium channel (IKr and IKs) blockers E4031 and Chromanol 293B, respectively, also prolonged QTc interval in a dose-dependent manner (523±25 ms and 529±27 ms, respectively, both p<0.01). Quinidine, E4031 and Chromanol 293B also decreased HR. Conclusions: Direct in-vitro recording of adult zebrafish heart is an efficient platform for test of drugs which exert electrophysiological effects on cardiomyocytes, and perturbation of ionic channels that are responsible for human long QT syndrome also modulates QT interval in adult zebrafish heart.

KW - electrocardiogram

KW - long QT

KW - zebrafish

UR - http://www.scopus.com/inward/record.url?scp=85009580544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009580544&partnerID=8YFLogxK

U2 - 10.4020/jhrs.27.OP32_2

DO - 10.4020/jhrs.27.OP32_2

M3 - Article

AN - SCOPUS:85009580544

VL - 27

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

IS - 4

ER -